Biosimilars: The New Era of Gastroenterology Management Considerations, Part 2: Biosimilars and Patients with Inflammatory Bowel Disease
Kenneth McQuaid, MD
UCSF School of Medicine
Edward Li, PharmD, MPH, BCOP
University of New England College of Pharmacy
Catherine Bauer, MSN, RN, MBA, CGRN, CFER
University of Virginia Medical Center
